According to the Zhitong Finance App, Shanghai Pharmaceutical (02607.HK) announced that Shangshi International, a wholly-owned subsidiary of Shangshi Group, the controlling shareholder of the company, increased its holding of 800,000 H shares on November 2, 2026. After this increase, Shangshi International held about 375 million H shares of the company, accounting for 10.119% of the company's total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.